INTC vs TMO: Which Is the Better Buy?
Side-by-side comparison of Intel Corporation and Thermo Fisher Scientific Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-04.
Intel Corporation · Technology
$82.54
-5.4% upside to fair value
Grade D
VS
Thermo Fisher Scientific Inc. · Healthcare
$462.60
+10.1% upside to fair value
Grade B
QuantHub Verdict
TMO has more upside to fair value
(+10.1%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
INTC |
TMO |
| Current Price |
$82.54 |
$462.60 |
| Fair Value Estimate |
$78.12 |
$509.20 |
| Upside to Fair Value |
-5.4%
|
+10.1%
|
| Market Cap |
$414.4B |
$171.9B |
| Forward P/E |
-132.2x
|
25.1x
|
| EV / EBITDA |
50.1x
|
19.0x
|
| Price / Sales |
7.7x
|
3.8x
|
| Price / FCF |
-132.9x
|
25.5x
|
| Revenue Growth YoY |
+7.2%
|
+6.2%
|
| Gross Margin |
35.4%
|
39.4%
|
| Operating Margin |
-9.4%
|
17.8%
|
| Return on Equity |
-3.0%
|
13.3%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
—
|
3.92%
|
| Analyst Consensus |
Hold
|
Strong Buy
|
Investment Thesis
Intel Corporation is a leading semiconductor company transitioning to a foundry business model while maintaining significant revenue from client computing and data center segments. Despite a strong market position and experienced leadership, the company faces earnings pressure with a 354% decline in earnings in the most recent quarter and negative margins. The stock trades at $82.54, which is 5.4…
Thermo Fisher Scientific Inc. operates in the healthcare sector, specializing in medical diagnostics and research tools across four main segments: Laboratory Products and Biopharma Services, Life Sciences Solutions, Analytical Instruments, and Specialty Diagnostics. The company demonstrates medium business quality with steady revenue growth of 6.2% and earnings growth of 9.6% in the most recent q…
Accumulation Zones
| Metric |
INTC |
TMO |
| Zone Low |
$58.59 |
$381.90 |
| Zone High |
$66.40 |
$432.82 |
| In Buy Zone? |
No
|
No
|